Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6272312 | 0.92 | TSHR (0.62) | TSHRCYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL25563177 | 0.91 | TSHR (0.59) | TSHRCYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL23003 | 0.87 | TSHR (0.79) | TSHRCYP2C9ALDH1A1HIF1ACAPN1 | |
| Butanedione SCHEMBL11340962 | 0.85 | TSHR (0.56) | TSHRCYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL28370887 | 0.85 | TSHR (0.76) | TSHRCYP2C9ALDH1A1HIF1ACAPN1 | |
| Ammonia Solution, Strong SCHEMBL27527756 | 0.85 | TSHR (0.76) | TSHRCYP2C9ALDH1A1HIF1ACAPN1 | |
| SCHEMBL11753259 | 0.85 | TSHR (0.59) | TSHRCYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL7505288 | 0.85 | TSHR (0.55) | TSHRCYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL22611874 | 0.85 | TSHR (0.58) | TSHRCYP1A2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL9018905 | 0.84 | TSHR (0.54) | TSHRCYP1A2CYP2D6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6797745-B1 | Hot melt inks containing styrene or terpene polymers | XEROX CORPORATION | 2004-09-28 | — | — | US | claimed |
| US-6461417-B1 | Ink compositions | XEROX CORPORATION | 2002-10-08 | — | — | US | claimed |
| US-4935413-A | ELASTICITY, ADHESION AND DISPERSIBILITY | NIPPON PAINT CO., LTD. (JP) | 1990-06-19 | — | — | US | claimed |
| EP-2289877-B1 | Organic light emitting device containing polycyclic heteroaryl compounds | SAMSUNG DISPLAY CO LTD (KR) | 2014-09-24 | — | — | EP | disclosed |
| US-8344365-B2 | Organic light emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-01-01 | — | — | US | disclosed |
| US-8263974-B2 | — | — | 2012-09-11 | — | — | US | disclosed |
| EP-2289877-A1 | Organic light emitting device containing polycyclic heteroaryl compounds | Samsung Mobile Display Co., Ltd. (KR) | 2011-03-02 | — | — | EP | disclosed |
| US-20110037060-A1 | ORGANIC LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2011-02-17 | — | — | US | disclosed |
| US-20070293600-A1 | Polycarbonate resin composition and medical appliances comprising thereof | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2007-12-20 | — | — | US | disclosed |
| EP-1829927-A1 | POLYCARBONATE RESIN COMPOSITION AND MEDICAL INSTRUMENT COMPRISING THE SAME | Mitsubishi Engineering-Plastics Corporation (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-6797745-B1 | Hot melt inks containing styrene or terpene polymers | XEROX CORPORATION | 2004-09-28 | — | — | US | disclosed |
| US-6461417-B1 | Ink compositions | XEROX CORPORATION | 2002-10-08 | — | — | US | disclosed |
| US-6359028-B1 | USED IN MEDICAL EQUIPMENT, DISCOLORATION INHIBITION | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2002-03-19 | — | — | US | disclosed |
| US-6040367-A | EXCELLENT RESISTANCE TO AN IONIZING RADIATION, IN WHICH HETEROCYCLIC COMPOUND CONTAINING OXYMETHYLENE UNITS | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2000-03-21 | — | — | US | disclosed |
| US-5977206-A | Polycarbonate resin composition | MITSUBISHI ENGINEERING-PLASTICS CORP. (JP) | 1999-11-02 | — | — | US | disclosed |
| US-5948838-A | 0.01 TO 5 PARTS BY WEIGHT OF A COMPOUND CONTAINING OXYMETHYLENE UNIT | MITSUBISHI ENGINEERING-PLASTICS CORP. (JP) | 1999-09-07 | — | — | US | disclosed |
| EP-0794218-A2 | Polycarbonate resin composition stabilized against radiation | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 1997-09-10 | — | — | EP | disclosed |
| EP-0753540-A2 | Polycarbonate resin composition | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 1997-01-15 | — | — | EP | disclosed |
| EP-0326249-A2 | Polymerizable compositions comprising Mannich bases and diaryliodonium photoinitiators. | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-08-02 | — | — | EP | disclosed |
| US-4791045-A | COATINGS; GRAPHIC ARTS; INCREASED PHOTOSENSITIVITY FOR ADDITION POLYMERIZATION | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1988-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110037060-A1 | ORGANIC LIGHT EMITTING DEVICE | TRPC1, TRPC4, TRPC3 | TSHR 4447/4885CYP1A2 216/4885CYP2D6 739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.